A glucagon-like peptide, structurally related The pancreatic islets of the holocephalan fishes contain, in addition to A-, B-and D-cells, X-cells, which are immunoreactive towards antisera directed against the N-terminal region of glucagon but not towards antisera directed against the C-terminal region. A 36-amino-acid-residue peptide was isolated from the pancreas of a holocephalan fish, the Pacific ratfish (Hydrolagus colliei), that shows homology (69%) to mammalian glucagon in its N-terminal region and is reactive towards an N-terminally directed antiserum. Reactivity towards C-terminally directed antisera is prevented by the presence of a 7-residue C-terminal extension to the glucagon sequence that shows limited homology to the C-terminal region of glucagon-37 (oxyntomodulin). It is proposed that this peptide represents a major storage product of the islet X-cell.
INTRODUCTION
The holocephalan fishes were the first class of vertebrate in evolution to develop a pancreatic gland with both exocrine and endocrine parenchyma (Fujita, 1962; Falkmer et al., 1984) . As in mammals, the endocrine tissue is localized to islets distributed throughout the pancreas, although isolated endocrine cells are found among the acinar tissue and in the epithelium of the pancreatic ducts. In the islets of the ratfish (Hydrolagus colliei), one such holocephalan fish, four types of endocrine cells have been described: A-cells containing glucagon, B-cells containing insulin, D-cells containing somatostatin, and X-cells (Patent, 1976; Falkmer, 1985) . Cells containing pancreatic polypeptide were present only in the gut mucosa and occasionally in the pancreatic-duct epithelium. A further immunohistochemical study (Stefan et al., 1981) has demonstrated that the X-cells are associated with an antigen that is detected with an antiserum that is directed against the N-terminal region of glucagon. The X-cells could not be immunostained with an antiserum directed against the C-terminal region of glucagon unless this immunodeterminant was first exposed by treatment of the sections with trypsin and carboxypeptidase B (Tager & Markese, 1979) . This result led to speculation that the X-cell of the ratfish, like the L-cell in the intestinal mucosa of mammals, stores higher-Mr or precursor forms of glucagon (Stefan et al., 1981) . The isolation and characterization of insulin from the ratfish pancreas has been described (Conlon et al., 1986) . In the present study side fractions from that preparation were examined with regionally specific antisera to pig glucagon for the presence of peptides with glucagon-like immunoreactivity. A 36-amino-acid-residue peptide was identified, which, it is speculated, may represent a storage product of the X-cell.
EXPERIMENTAL
Ratfish (about 600 adult specimens; body wt. 1-3 kg) were collected at Bamfield Marine Station (Vancouver Island, B.C., Canada) during October and November. The extraction of pancreatic tissue (203 g) with ethanol/0.7 M-HCl (3:1, v/v) has been described previously (Conlon et al., 1986) . Ethanol was removed from the extract under reduced pressure, and the resulting solution was centrifuged (20000 g for 1 h at 4°C). The supernatant from half of the extract was pumped at a flow rate of 1 ml/min on to eight Sep-pak C18 cartridges (Waters Associates, Milford, MA, U.S.A.) connected in series. Bound material was eluted with acetonitrile/ water/trifluoroacetic acid (70:29:1, by vol.) and the effluent was freeze-dried. Radioimnunoassay methods Glucagon-like immunoreactivity was measured with an antiserum directed against a site in the N-terminal to central region of glucagon (probably residues 10-18) . This antiserum cross-reacts fully with highly purified glicentin (Thim & Moody, 1981) and with synthetic oxyntomodulin (glucagon-37) (Bataille et al., 1982) . These measurements were referred to as 'N-terminal glucagon-like immunoreactivity' (N-GLI), and antisera of this specificity have been termed 'gut GLI cross-reactive'. Measurements were also made with the well-characterized Unger antiserum 30K (Faloona & Unger, 1974) , directed against a site in the C-terminal region of glucagon (probably residues 24-29). The antiserum requires a free carboxy group on Thr-29 of glucagon for reactivity (Conlon, 1981) . These measurements are termed 'C-terminal glucagon-like immunoreactivity' (C-GLI), and antisera of this specificity have been described as 'pancreatic glucagon specific'. All data are expressed relative to a pig glucagon standard The pancreatic extract, after concentration on Sep-pak cartridges, was chromatographed on a column (90 cm x 1.6 cm) of Sephadex G-50 (fine grade) equilibrated with 0.1 M-ammonium acetate, pH 6.8. Fractions (2.1 ml) were assayed at a dilution of 1: 500 for glucagon-like immunoreactivity. Fractions with Kay between 0.23 and 0.42 (hatched bar in Fig. 1 portions on to an Ultrapore RPSC column (0.46 cm x 7.5 cm) (Beckman/Altex, Berkeley, CA, U.S.A.) equilibrated with 0.1% trifluoroacetic acid at 30°C and at 1.5 ml/min. The concentration of acetonitrile in the eluting solvent was raised to 17.5% (v/v) over 5 min, followed by an increase to 28% (v/v) over 35 min. The u.v.-absorbing peak with glucagon-like immunoreactivity ( Fig. 3 ) was purified to homogeneity on a Supelcosil LC-3DP column (0.46 cm x 25 cm) (Supelco, Bellefonte, PA, U.S.A.) equilibrated with 0.1 % trifluoroacetic acid at 30°C and at 1.5 ml/min. The concentration of acetonitrile in the eluting solvent was raised to 28% (v/v) over 5 min, followed by an increase to 35% (v/v) over 35 min (Fig. 4) .
Structural characterization of the peptide
The amino acid composition of the glucagon-related peptide was determined with a Durrum D-500 automatic analyser as previously described (Conlon & McCarthy, 1984) . Approx. 2 nmol of peptide was used. The primary structure of the peptide was determined by automated Edman degradation in an Applied Biosystems model 470A gas-phase sequencer (Moody et al., 1984) . Approx. 5 nmol of peptide was used and the detection limit for amino acid phenylthiohydantoin derivatives was 0.5 pmol.
RESULTS

Glucagon-like immunoreactivities in ratfish pancreatic extracts
The ratfish pancreatic extract contained 690 pmol of glucagon-like immunoreactivity/g, measured with an antiserum directed against the N-terminal to central region of glucagon (N-GLI) and 67 pmol/g measured with an antiserum directed against the C-terminal region of glucagon (C-GLI). The immunoreactivity in serial dilutions of the pancreatic extracts gave rise to a line that was parallel to that for the pig glucagon standard in a radioimmunoassay with the N-terminally directed anti- partial purification by gel Mtration (Fig. 1) Details of the elution conditions are given in the text; -----, concn. of acetonitrile in the eluting solvent. The peak denoted by the arrow contained glucagon-like immunoreactivity and was purified further. peptide from the pancreas of the raffish serum. However, the immunoreactivity measured with the C-terminally directed antiserum did not dilute in parallel with the standard, so that the concentration of C-GLI measured by radioimmunoassay in the extract should be regarded only as an approximation. The N-GLI was resolved by gel filtration into multiple molecular forms, whereas the C-GLI was eluted from the column as a single peak with approximately the same elution volume as pig glucagon (Fig. 1) . Only the major peak denoted by the hatched bar was selected for further purification.
H.p.l.c.
Fractions from gel filtration containing N-GLI (denoted by the hatched bar in Fig. 1 ) were chromatographed on a Vydac wide-pore C18 reverse-phase column (Fig. 2) . The peak denoted by the arrow was associated with N-GLI and was purified further on an Ultrasphere C3 (n-propyldimethylsilylsilica) column. The peak was resolved into at least three components (Fig. 3 ), but only the major peak denoted by the asterisk was associated with N-GLI. The glucagon-related peptide was purified to homogeneity by chromatography on a Supelcosil LC-3DP (diphenylmethylsilylsilica) column (Fig. 4) . The final yield of pure material, starting from 50% of the original extract, was approx. 12 nmol.
This represents a yield of 17% of the N-GLI in the starting material.
Structural analysis
The amino acid composition of the glucagon-related peptide is shown in Agreement between the proposed sequence and the amino acid composition was good, indicating that the full sequence of the peptide has been obtained. An independent determination of the C-terminal residue was not carried out, and so the possibility that the sequence extends beyond residue 36 cannot be excluded entirely. The immunochemical properties of the peptide are consistent with the proposed structure. The strong homology with pig glucagon in the central region of the molecule (residues 8-15 and 17-18) accounts for the presence of N-GLI, and the presence of a C-terminal polypeptide extension to the Thr-29 residue accounts for the absence of C-GLI (Fig. 5 ).
Vol. 245 
DISCUSSION
The results of the present study confirm previous immunohistochemical observations (Stefan et al., 1981) that the ratfish pancreas contains much higher concentrations of glucagon-like immunoreactivity measured with a N-terminally directed antiserum than with a C-terminally directed antiserum. One abundant peptide with N-terminal glucagon-like immunoreactivity was purified to homogeneity, and its structure is compared with pig glucagon, pig oxyntomodulin (glucagon-37) and glucagofi from an elasmobranchian fish, Torpedo marmorata (Conlon & Thim, 1985) , in Fig. 5 . The N-terminal region of the ratfish peptide (residues 1-29)
shows homology to glucagon from the pig (69%) and Torpedo (76%), and the C-terminal extension to the glucagon sequence shows identity in four out of seven amino acid residues with the corresponding extension in pig oxyntomodulin. The holocephalan fishes are phylogenetically related to the elasmobranchian fishes, but diverged from the line of evolution leading to contemporary sharks and rays at least 250 million years ago. Nevertheless, the unusual structural features of Asn-16 and Lys-20 found in Torpedo glucagon are also found in the ratfish peptide. Glucagon-37 was first isolated as a contaminant in a commercially available mixture of pig and bovine glucagons (Tager & Steiner, 1973) , and was subsequently purified from extracts of pig small intestine (Bataille et al., 1982) . The concentration of this component in the pancreas of most mammalian species studied is low (Conlon, 1981) , but in the guinea pig a difference in the primary structure of glucagon Huang et al., 1986 ) is accompanied by a much higher concentration of glucagon-37 .
The immunohistochemical study by Stefan et al. (1981) demonstrated that the ratfish pancreatic islets contained two populations of cells with different glucagon immunoreactivity. It is proposed that the 36-aminoacid-residue peptide isolated in this study is a storage product of the X-cells, i.e. those cells that may be stained with the N-terminally directed serum but not the C-terminally directed antiserum to glucagon. The gel-filtration profile shown in Fig. 1 indicates that the X-cell may also store, in lower concentration, higher-Mr glucagon-like peptides that may be more similar in structure to pig glicentin. Attempts to purify the glucagon-like peptide with C-terminal immunoreactivity (Fig. 1) have not yet been successful. However, since the C-terminally directed antiserum will only recognize glucagon-like peptides with a free Thr-29 residue (Conlon, 1981) , it is probable that this peptide represents residues 1-29 of the larger peptide purified in the present study. The presence of amino acid substitutions at positions 27 (leucine for methionine) and 28 (serine for asparagine) in the ratfish sequence probably means that the concentration of C-terminal immunoreactivity in the ratfish pancreas, measured by radioimmunoassay and shown in Fig. 1 , is greatly underestimated.
Mutations in the guinea-pig preproglucagon gene are largely restricted to the C-terminal region of the glucagon sequence (Seino et al., 1986) . As this region is involved in binding to the receptor, it has been speculated that the changes in structure are an adaptive response to divergence in primary structure of guinea-pig insulin. The amino acid sequence of ratfish insulin shows some unique structure features, in particular an extension to the B-chain, which are expected to result in marked changes in biological potency (Conlon et al., 1986) . It is therefore tempting to speculate that, in the ratfish also, changes in the pathway of post-translational processing of proglucagon and substitutions in the C-terminal region of glucagon are an adaptive response to overcome the metabolic imbalance that would result from an insulin and a glucagon of appreciably different potencies in the same species.
